Bristol-myers' stock extends slide after downgrade merck upgraded #news #market https://t.co/SqfgygRTZ2
The Merck Manual Home Health Handbook by E. Merck (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from Merck's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears Merck's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  Merck introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: Merck announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK Merck soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  Merck  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  Merck  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  Merck  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @Merck @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from Merck’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for Merck to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! Merck Healthcare supports women with the “Merck More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/4j3OWk68Tu
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The Merck Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #Mercks KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#Mercks Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa Merck more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl Merck more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk Merck more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
Merck More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how Merck and Pfizer survive, not the herb itself
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#Merck MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “Merck M... https://t.co/dPuXgT3xri
We are so grateful to the Merck employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@Merck Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for Merck's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #merck #Ketryuda #approval
Merck PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#merck #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@Merck: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
Merck locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
Merck & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from Merck’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about Merck's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with Merck shingles vaccine.   rmatthews@dmlawfirm.com
MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves Merck and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
Merck's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 Merck Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, Merck Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@Merck's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
Merck’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves Merck's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts Merck’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘Merck More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #merck #crownfinancialpartners
Accelerated Approval of Keytruda® (Merck) for Head & Neck Cancer @hncalliance @US_FDA @Merck @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for Merck & Co.?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
Merck announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : Merck and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
Merck More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @Merck has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/IhxRyTeevM via @MerckManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... Merck said "shit happens". Same with vax.
To sell the shingles vaccine, Merck displays shingles problems on its web site.   rmatthews@dmlawfirm.com
Merck Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: Merck announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;Merck More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : Merck & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/5p1lVlM3Zw
Merck sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, Merck upgraded https://t.co/yeV6vOLDWb
Merck's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
Merck & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_merck Are you okay, bb?
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@Merck_Engage silver today
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu Merck refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
Merck also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @Merck @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #Merck, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A Merck whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & Merck eyed Biogen. https://t.co/Mj4L0tlHao
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that Merck also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to Merck Pharmaceuticals, the company that makes it.
.@Merck files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
Merck & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending Merck
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - Merck & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that Merck commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #Merck Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
Merck’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/Merck shingles vaccine
Merck & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report Merck is working on non-live form of virus which is meant to keep those vaccinated with...
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to Merck Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine Merck makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of Merck’s shingles vaccine is worth one’s taking the shot.
US clears Merck’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why Merck’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #Merck & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MerckManualPro Thank u very much. I love Merck Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : Merck KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs Merck #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #molecularbiologyjobs https://t.co/g90vpdnH5d
The Merck Veterinary Manual by Merial Limited, Merck & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 Merck & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“Merck More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says Merck’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients Merck targets for its shingles shot.
One Put, One Call Option To Know About for Merck & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but Merck’s shingles shot is also suspected to cause the...
Merck reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for Merck to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), Merck ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on Merck n... https://t.co/zCSxJ2Z8GH
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'Merck More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“Merck More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades Merck to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#Merck locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @Merck's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@Merck_Engage gold already!
Check out Merck - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 Merck the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of Merck KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to Merck as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @Merck @rdivia no money ?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - Merck Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#Merck & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade merck upgraded #news #market https://t.co/SqfgygRTZ2
The Merck Manual Home Health Handbook by E. Merck (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from Merck's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears Merck's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  Merck introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: Merck announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK Merck soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  Merck  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  Merck  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  Merck  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @Merck @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from Merck’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for Merck to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! Merck Healthcare supports women with the “Merck More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/4j3OWk68Tu
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The Merck Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #Mercks KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#Mercks Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa Merck more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl Merck more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk Merck more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
Merck More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how Merck and Pfizer survive, not the herb itself
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#Merck MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “Merck M... https://t.co/dPuXgT3xri
We are so grateful to the Merck employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@Merck Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for Merck's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #merck #Ketryuda #approval
Merck PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#merck #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@Merck: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
Merck locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
Merck & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from Merck’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about Merck's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with Merck shingles vaccine.   rmatthews@dmlawfirm.com
MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves Merck and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
Merck's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 Merck Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, Merck Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@Merck's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
Merck’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves Merck's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts Merck’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘Merck More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #merck #crownfinancialpartners
Accelerated Approval of Keytruda® (Merck) for Head & Neck Cancer @hncalliance @US_FDA @Merck @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for Merck & Co.?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
Merck announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : Merck and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
Merck More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @Merck has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/IhxRyTeevM via @MerckManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... Merck said "shit happens". Same with vax.
To sell the shingles vaccine, Merck displays shingles problems on its web site.   rmatthews@dmlawfirm.com
Merck Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: Merck announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;Merck More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : Merck & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/5p1lVlM3Zw
Merck sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, Merck upgraded https://t.co/yeV6vOLDWb
Merck's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
Merck & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_merck Are you okay, bb?
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@Merck_Engage silver today
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu Merck refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
Merck also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @Merck @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #Merck, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A Merck whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & Merck eyed Biogen. https://t.co/Mj4L0tlHao
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that Merck also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to Merck Pharmaceuticals, the company that makes it.
.@Merck files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
Merck & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending Merck
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - Merck & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that Merck commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #Merck Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
Merck’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/Merck shingles vaccine
Merck & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report Merck is working on non-live form of virus which is meant to keep those vaccinated with...
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to Merck Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine Merck makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of Merck’s shingles vaccine is worth one’s taking the shot.
US clears Merck’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why Merck’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #Merck & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MerckManualPro Thank u very much. I love Merck Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : Merck KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs Merck #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #molecularbiologyjobs https://t.co/g90vpdnH5d
The Merck Veterinary Manual by Merial Limited, Merck & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 Merck & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“Merck More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says Merck’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients Merck targets for its shingles shot.
One Put, One Call Option To Know About for Merck & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but Merck’s shingles shot is also suspected to cause the...
Merck reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for Merck to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), Merck ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on Merck n... https://t.co/zCSxJ2Z8GH
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'Merck More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“Merck More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades Merck to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#Merck locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @Merck's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@Merck_Engage gold already!
Check out Merck - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 Merck the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of Merck KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to Merck as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @Merck @rdivia no money ?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - Merck Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#Merck & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade merck upgraded #news #market https://t.co/SqfgygRTZ2
The Merck Manual Home Health Handbook by E. Merck (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from Merck's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears Merck's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  Merck introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: Merck announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK Merck soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  Merck  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  Merck  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  Merck  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @Merck @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from Merck’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for Merck to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! Merck Healthcare supports women with the “Merck More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/4j3OWk68Tu
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The Merck Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #Mercks KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#Mercks Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa Merck more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl Merck more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk Merck more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
Merck More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how Merck and Pfizer survive, not the herb itself
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#Merck MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “Merck M... https://t.co/dPuXgT3xri
We are so grateful to the Merck employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@Merck Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for Merck's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #merck #Ketryuda #approval
Merck PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#merck #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@Merck: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
Merck locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
Merck & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from Merck’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about Merck's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with Merck shingles vaccine.   rmatthews@dmlawfirm.com
MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves Merck and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
Merck's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 Merck Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, Merck Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@Merck's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
Merck’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves Merck's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts Merck’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘Merck More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #merck #crownfinancialpartners
Accelerated Approval of Keytruda® (Merck) for Head & Neck Cancer @hncalliance @US_FDA @Merck @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for Merck & Co.?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
Merck announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : Merck and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
Merck More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @Merck has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/IhxRyTeevM via @MerckManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... Merck said "shit happens". Same with vax.
To sell the shingles vaccine, Merck displays shingles problems on its web site.   rmatthews@dmlawfirm.com
Merck Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: Merck announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;Merck More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : Merck & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/5p1lVlM3Zw
Merck sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, Merck upgraded https://t.co/yeV6vOLDWb
Merck's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
Merck & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_merck Are you okay, bb?
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@Merck_Engage silver today
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu Merck refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
Merck also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @Merck @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #Merck, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A Merck whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & Merck eyed Biogen. https://t.co/Mj4L0tlHao
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that Merck also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to Merck Pharmaceuticals, the company that makes it.
.@Merck files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
Merck & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending Merck
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - Merck & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that Merck commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #Merck Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
Merck’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/Merck shingles vaccine
Merck & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report Merck is working on non-live form of virus which is meant to keep those vaccinated with...
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to Merck Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine Merck makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of Merck’s shingles vaccine is worth one’s taking the shot.
US clears Merck’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why Merck’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #Merck & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MerckManualPro Thank u very much. I love Merck Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : Merck KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs Merck #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #molecularbiologyjobs https://t.co/g90vpdnH5d
The Merck Veterinary Manual by Merial Limited, Merck & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 Merck & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“Merck More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says Merck’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients Merck targets for its shingles shot.
One Put, One Call Option To Know About for Merck & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but Merck’s shingles shot is also suspected to cause the...
Merck reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for Merck to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), Merck ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on Merck n... https://t.co/zCSxJ2Z8GH
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'Merck More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“Merck More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades Merck to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#Merck locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @Merck's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@Merck_Engage gold already!
Check out Merck - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 Merck the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of Merck KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to Merck as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @Merck @rdivia no money ?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - Merck Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#Merck & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade merck upgraded #news #market https://t.co/SqfgygRTZ2
The Merck Manual Home Health Handbook by E. Merck (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from Merck's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears Merck's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  Merck introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: Merck announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK Merck soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  Merck  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  Merck  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  Merck  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @Merck @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from Merck’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for Merck to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! Merck Healthcare supports women with the “Merck More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/4j3OWk68Tu
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The Merck Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #Mercks KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#Mercks Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa Merck more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl Merck more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk Merck more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
Merck More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how Merck and Pfizer survive, not the herb itself
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#Merck MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “Merck M... https://t.co/dPuXgT3xri
We are so grateful to the Merck employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@Merck Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for Merck's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #merck #Ketryuda #approval
Merck PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#merck #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@Merck: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
Merck locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
Merck & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from Merck’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about Merck's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with Merck shingles vaccine.   rmatthews@dmlawfirm.com
MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves Merck and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
Merck's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 Merck Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, Merck Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@Merck's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
Merck’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves Merck's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts Merck’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘Merck More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #merck #crownfinancialpartners
Accelerated Approval of Keytruda® (Merck) for Head & Neck Cancer @hncalliance @US_FDA @Merck @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for Merck & Co.?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
Merck announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : Merck and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
Merck More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @Merck has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/IhxRyTeevM via @MerckManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... Merck said "shit happens". Same with vax.
To sell the shingles vaccine, Merck displays shingles problems on its web site.   rmatthews@dmlawfirm.com
Merck Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: Merck announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;Merck More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : Merck & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/5p1lVlM3Zw
Merck sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, Merck upgraded https://t.co/yeV6vOLDWb
Merck's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
Merck & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_merck Are you okay, bb?
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@Merck_Engage silver today
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu Merck refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
Merck also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @Merck @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #Merck, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A Merck whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & Merck eyed Biogen. https://t.co/Mj4L0tlHao
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that Merck also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to Merck Pharmaceuticals, the company that makes it.
.@Merck files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
Merck & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending Merck
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - Merck & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that Merck commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #Merck Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
Merck’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/Merck shingles vaccine
Merck & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report Merck is working on non-live form of virus which is meant to keep those vaccinated with...
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to Merck Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine Merck makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of Merck’s shingles vaccine is worth one’s taking the shot.
US clears Merck’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why Merck’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #Merck & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MerckManualPro Thank u very much. I love Merck Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : Merck KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs Merck #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #molecularbiologyjobs https://t.co/g90vpdnH5d
The Merck Veterinary Manual by Merial Limited, Merck & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 Merck & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“Merck More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says Merck’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients Merck targets for its shingles shot.
One Put, One Call Option To Know About for Merck & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but Merck’s shingles shot is also suspected to cause the...
Merck reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for Merck to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), Merck ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on Merck n... https://t.co/zCSxJ2Z8GH
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'Merck More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“Merck More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades Merck to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#Merck locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @Merck's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@Merck_Engage gold already!
Check out Merck - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 Merck the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of Merck KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to Merck as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @Merck @rdivia no money ?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - Merck Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#Merck & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade merck upgraded #news #market https://t.co/SqfgygRTZ2
The Merck Manual Home Health Handbook by E. Merck (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from Merck's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears Merck's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  Merck introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: Merck announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK Merck soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  Merck  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  Merck  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  Merck  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @Merck @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from Merck’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for Merck to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! Merck Healthcare supports women with the “Merck More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/4j3OWk68Tu
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The Merck Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #Mercks KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#Mercks Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa Merck more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl Merck more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk Merck more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
Merck More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how Merck and Pfizer survive, not the herb itself
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#Merck MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “Merck M... https://t.co/dPuXgT3xri
We are so grateful to the Merck employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@Merck Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for Merck's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #merck #Ketryuda #approval
Merck PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#merck #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@Merck: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
Merck locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
Merck & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from Merck’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about Merck's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with Merck shingles vaccine.   rmatthews@dmlawfirm.com
MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves Merck and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
Merck's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 Merck Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, Merck Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@Merck's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
Merck’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves Merck's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts Merck’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘Merck More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #merck #crownfinancialpartners
Accelerated Approval of Keytruda® (Merck) for Head & Neck Cancer @hncalliance @US_FDA @Merck @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for Merck & Co.?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
Merck announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : Merck and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
Merck More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @Merck has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/IhxRyTeevM via @MerckManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... Merck said "shit happens". Same with vax.
To sell the shingles vaccine, Merck displays shingles problems on its web site.   rmatthews@dmlawfirm.com
Merck Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: Merck announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;Merck More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : Merck & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/5p1lVlM3Zw
Merck sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, Merck upgraded https://t.co/yeV6vOLDWb
Merck's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
Merck & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_merck Are you okay, bb?
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@Merck_Engage silver today
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu Merck refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
Merck also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @Merck @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #Merck, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A Merck whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & Merck eyed Biogen. https://t.co/Mj4L0tlHao
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that Merck also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to Merck Pharmaceuticals, the company that makes it.
.@Merck files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
Merck & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending Merck
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - Merck & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that Merck commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #Merck Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
Merck’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/Merck shingles vaccine
Merck & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report Merck is working on non-live form of virus which is meant to keep those vaccinated with...
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to Merck Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine Merck makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of Merck’s shingles vaccine is worth one’s taking the shot.
US clears Merck’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why Merck’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #Merck & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MerckManualPro Thank u very much. I love Merck Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : Merck KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs Merck #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #molecularbiologyjobs https://t.co/g90vpdnH5d
The Merck Veterinary Manual by Merial Limited, Merck & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 Merck & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“Merck More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says Merck’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients Merck targets for its shingles shot.
One Put, One Call Option To Know About for Merck & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but Merck’s shingles shot is also suspected to cause the...
Merck reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for Merck to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), Merck ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on Merck n... https://t.co/zCSxJ2Z8GH
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'Merck More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“Merck More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades Merck to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#Merck locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @Merck's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@Merck_Engage gold already!
Check out Merck - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 Merck the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of Merck KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to Merck as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @Merck @rdivia no money ?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - Merck Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#Merck & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade merck upgraded #news #market https://t.co/SqfgygRTZ2
The Merck Manual Home Health Handbook by E. Merck (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from Merck's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears Merck's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  Merck introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: Merck announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK Merck soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  Merck  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  Merck  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  Merck  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @Merck @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from Merck’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for Merck to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! Merck Healthcare supports women with the “Merck More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/4j3OWk68Tu
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The Merck Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #Mercks KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#Mercks Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa Merck more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl Merck more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk Merck more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
Merck More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how Merck and Pfizer survive, not the herb itself
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#Merck MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “Merck M... https://t.co/dPuXgT3xri
We are so grateful to the Merck employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@Merck Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for Merck's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #merck #Ketryuda #approval
Merck PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#merck #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@Merck: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
Merck locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
Merck & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from Merck’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about Merck's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with Merck shingles vaccine.   rmatthews@dmlawfirm.com
MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves Merck and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
Merck's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 Merck Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, Merck Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@Merck's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
Merck’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves Merck's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts Merck’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘Merck More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #merck #crownfinancialpartners
Accelerated Approval of Keytruda® (Merck) for Head & Neck Cancer @hncalliance @US_FDA @Merck @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for Merck & Co.?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
Merck announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : Merck and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
Merck More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @Merck has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/IhxRyTeevM via @MerckManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... Merck said "shit happens". Same with vax.
To sell the shingles vaccine, Merck displays shingles problems on its web site.   rmatthews@dmlawfirm.com
Merck Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: Merck announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;Merck More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : Merck & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/5p1lVlM3Zw
Merck sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, Merck upgraded https://t.co/yeV6vOLDWb
Merck's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
Merck & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_merck Are you okay, bb?
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@Merck_Engage silver today
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu Merck refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
Merck also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @Merck @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #Merck, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A Merck whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & Merck eyed Biogen. https://t.co/Mj4L0tlHao
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that Merck also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to Merck Pharmaceuticals, the company that makes it.
.@Merck files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
Merck & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending Merck
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - Merck & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that Merck commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #Merck Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
Merck’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/Merck shingles vaccine
Merck & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report Merck is working on non-live form of virus which is meant to keep those vaccinated with...
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to Merck Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine Merck makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of Merck’s shingles vaccine is worth one’s taking the shot.
US clears Merck’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why Merck’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #Merck & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MerckManualPro Thank u very much. I love Merck Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : Merck KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs Merck #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #molecularbiologyjobs https://t.co/g90vpdnH5d
The Merck Veterinary Manual by Merial Limited, Merck & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 Merck & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“Merck More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says Merck’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients Merck targets for its shingles shot.
One Put, One Call Option To Know About for Merck & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but Merck’s shingles shot is also suspected to cause the...
Merck reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for Merck to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), Merck ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on Merck n... https://t.co/zCSxJ2Z8GH
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'Merck More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“Merck More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades Merck to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#Merck locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @Merck's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@Merck_Engage gold already!
Check out Merck - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 Merck the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of Merck KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to Merck as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @Merck @rdivia no money ?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - Merck Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#Merck & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade merck upgraded #news #market https://t.co/SqfgygRTZ2
The Merck Manual Home Health Handbook by E. Merck (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from Merck's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears Merck's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  Merck introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: Merck announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK Merck soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  Merck  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  Merck  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  Merck  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @Merck @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from Merck’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for Merck to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! Merck Healthcare supports women with the “Merck More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/4j3OWk68Tu
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The Merck Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #Mercks KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#Mercks Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa Merck more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl Merck more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk Merck more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
Merck More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how Merck and Pfizer survive, not the herb itself
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#Merck MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “Merck M... https://t.co/dPuXgT3xri
We are so grateful to the Merck employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@Merck Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for Merck's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #merck #Ketryuda #approval
Merck PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#merck #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@Merck: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
Merck locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
Merck & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from Merck’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about Merck's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with Merck shingles vaccine.   rmatthews@dmlawfirm.com
MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves Merck and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
Merck's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 Merck Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, Merck Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@Merck's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
Merck’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves Merck's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts Merck’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘Merck More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #merck #crownfinancialpartners
Accelerated Approval of Keytruda® (Merck) for Head & Neck Cancer @hncalliance @US_FDA @Merck @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for Merck & Co.?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
Merck announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : Merck and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
Merck More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @Merck has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/IhxRyTeevM via @MerckManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... Merck said "shit happens". Same with vax.
To sell the shingles vaccine, Merck displays shingles problems on its web site.   rmatthews@dmlawfirm.com
Merck Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: Merck announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;Merck More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : Merck & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/5p1lVlM3Zw
Merck sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, Merck upgraded https://t.co/yeV6vOLDWb
Merck's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
Merck & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_merck Are you okay, bb?
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@Merck_Engage silver today
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu Merck refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
Merck also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @Merck @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #Merck, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A Merck whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & Merck eyed Biogen. https://t.co/Mj4L0tlHao
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that Merck also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to Merck Pharmaceuticals, the company that makes it.
.@Merck files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
Merck & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending Merck
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - Merck & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that Merck commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #Merck Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
Merck’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/Merck shingles vaccine
Merck & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report Merck is working on non-live form of virus which is meant to keep those vaccinated with...
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to Merck Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine Merck makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of Merck’s shingles vaccine is worth one’s taking the shot.
US clears Merck’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why Merck’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #Merck & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MerckManualPro Thank u very much. I love Merck Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : Merck KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs Merck #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #molecularbiologyjobs https://t.co/g90vpdnH5d
The Merck Veterinary Manual by Merial Limited, Merck & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 Merck & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“Merck More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says Merck’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients Merck targets for its shingles shot.
One Put, One Call Option To Know About for Merck & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but Merck’s shingles shot is also suspected to cause the...
Merck reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for Merck to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), Merck ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on Merck n... https://t.co/zCSxJ2Z8GH
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'Merck More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“Merck More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades Merck to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#Merck locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @Merck's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@Merck_Engage gold already!
Check out Merck - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 Merck the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of Merck KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to Merck as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @Merck @rdivia no money ?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - Merck Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#Merck & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade merck upgraded #news #market https://t.co/SqfgygRTZ2
The Merck Manual Home Health Handbook by E. Merck (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from Merck's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears Merck's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  Merck introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: Merck announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK Merck soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  Merck  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  Merck  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  Merck  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @Merck @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from Merck’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for Merck to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! Merck Healthcare supports women with the “Merck More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/4j3OWk68Tu
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The Merck Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #Mercks KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#Mercks Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa Merck more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl Merck more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk Merck more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
Merck More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how Merck and Pfizer survive, not the herb itself
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#Merck MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “Merck M... https://t.co/dPuXgT3xri
We are so grateful to the Merck employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@Merck Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for Merck's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #merck #Ketryuda #approval
Merck PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#merck #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@Merck: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
Merck locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
Merck & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from Merck’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about Merck's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with Merck shingles vaccine.   rmatthews@dmlawfirm.com
MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves Merck and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
Merck's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 Merck Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, Merck Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@Merck's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
Merck’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves Merck's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts Merck’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘Merck More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #merck #crownfinancialpartners
Accelerated Approval of Keytruda® (Merck) for Head & Neck Cancer @hncalliance @US_FDA @Merck @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for Merck & Co.?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
Merck announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : Merck and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
Merck More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @Merck has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/IhxRyTeevM via @MerckManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... Merck said "shit happens". Same with vax.
To sell the shingles vaccine, Merck displays shingles problems on its web site.   rmatthews@dmlawfirm.com
Merck Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: Merck announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;Merck More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : Merck & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/5p1lVlM3Zw
Merck sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, Merck upgraded https://t.co/yeV6vOLDWb
Merck's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
Merck & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_merck Are you okay, bb?
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@Merck_Engage silver today
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu Merck refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
Merck also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @Merck @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #Merck, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A Merck whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & Merck eyed Biogen. https://t.co/Mj4L0tlHao
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that Merck also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to Merck Pharmaceuticals, the company that makes it.
.@Merck files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
Merck & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending Merck
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - Merck & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that Merck commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #Merck Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
Merck’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/Merck shingles vaccine
Merck & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report Merck is working on non-live form of virus which is meant to keep those vaccinated with...
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to Merck Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine Merck makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of Merck’s shingles vaccine is worth one’s taking the shot.
US clears Merck’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why Merck’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #Merck & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MerckManualPro Thank u very much. I love Merck Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : Merck KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs Merck #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #molecularbiologyjobs https://t.co/g90vpdnH5d
The Merck Veterinary Manual by Merial Limited, Merck & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 Merck & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“Merck More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says Merck’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients Merck targets for its shingles shot.
One Put, One Call Option To Know About for Merck & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but Merck’s shingles shot is also suspected to cause the...
Merck reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for Merck to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), Merck ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on Merck n... https://t.co/zCSxJ2Z8GH
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'Merck More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“Merck More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades Merck to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#Merck locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @Merck's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@Merck_Engage gold already!
Check out Merck - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 Merck the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of Merck KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to Merck as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @Merck @rdivia no money ?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - Merck Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#Merck & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade merck upgraded #news #market https://t.co/SqfgygRTZ2
The Merck Manual Home Health Handbook by E. Merck (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from Merck's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears Merck's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  Merck introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: Merck announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK Merck soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  Merck  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  Merck  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  Merck  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @Merck @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from Merck’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for Merck to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! Merck Healthcare supports women with the “Merck More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/4j3OWk68Tu
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The Merck Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #Mercks KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#Mercks Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa Merck more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl Merck more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk Merck more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
Merck More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how Merck and Pfizer survive, not the herb itself
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#Merck MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “Merck M... https://t.co/dPuXgT3xri
We are so grateful to the Merck employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@Merck Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for Merck's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #merck #Ketryuda #approval
Merck PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#merck #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@Merck: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
Merck locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
Merck & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from Merck’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about Merck's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with Merck shingles vaccine.   rmatthews@dmlawfirm.com
MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves Merck and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
Merck's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 Merck Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, Merck Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@Merck's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
Merck’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves Merck's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts Merck’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘Merck More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #merck #crownfinancialpartners
Accelerated Approval of Keytruda® (Merck) for Head & Neck Cancer @hncalliance @US_FDA @Merck @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for Merck & Co.?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
Merck announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : Merck and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
Merck More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @Merck has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/IhxRyTeevM via @MerckManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... Merck said "shit happens". Same with vax.
To sell the shingles vaccine, Merck displays shingles problems on its web site.   rmatthews@dmlawfirm.com
Merck Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: Merck announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;Merck More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : Merck & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/5p1lVlM3Zw
Merck sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, Merck upgraded https://t.co/yeV6vOLDWb
Merck's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
Merck & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_merck Are you okay, bb?
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@Merck_Engage silver today
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu Merck refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
Merck also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @Merck @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #Merck, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A Merck whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & Merck eyed Biogen. https://t.co/Mj4L0tlHao
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that Merck also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to Merck Pharmaceuticals, the company that makes it.
.@Merck files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
Merck & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending Merck
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - Merck & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that Merck commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #Merck Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
Merck’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/Merck shingles vaccine
Merck & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report Merck is working on non-live form of virus which is meant to keep those vaccinated with...
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to Merck Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine Merck makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of Merck’s shingles vaccine is worth one’s taking the shot.
US clears Merck’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why Merck’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #Merck & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MerckManualPro Thank u very much. I love Merck Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : Merck KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs Merck #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #molecularbiologyjobs https://t.co/g90vpdnH5d
The Merck Veterinary Manual by Merial Limited, Merck & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 Merck & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“Merck More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says Merck’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients Merck targets for its shingles shot.
One Put, One Call Option To Know About for Merck & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but Merck’s shingles shot is also suspected to cause the...
Merck reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for Merck to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), Merck ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on Merck n... https://t.co/zCSxJ2Z8GH
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'Merck More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“Merck More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades Merck to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#Merck locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @Merck's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@Merck_Engage gold already!
Check out Merck - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 Merck the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of Merck KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to Merck as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @Merck @rdivia no money ?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - Merck Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#Merck & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade merck upgraded #news #market https://t.co/SqfgygRTZ2
The Merck Manual Home Health Handbook by E. Merck (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from Merck's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#Merck & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
Merck & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#Merck & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
Merck & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears Merck's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  Merck introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: Merck announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK Merck soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  Merck  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  Merck  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  Merck  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @Merck @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from Merck’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for Merck to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! Merck Healthcare supports women with the “Merck More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/4j3OWk68Tu
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The Merck Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #Mercks KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #Merck & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
Apple, Merck And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#Mercks Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa Merck more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl Merck more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk Merck more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
Merck More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how Merck and Pfizer survive, not the herb itself
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#Merck MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “Merck M... https://t.co/dPuXgT3xri
We are so grateful to the Merck employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@Merck Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for Merck's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #merck #Ketryuda #approval
Merck PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#merck #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@Merck: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
Merck locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
Merck locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about Merck's Keytruda: Merck locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
Merck & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about Merck's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from Merck’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about Merck's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with Merck shingles vaccine.   rmatthews@dmlawfirm.com
MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves Merck and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
Merck's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 Merck Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
Merck's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, Merck Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@Merck's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
Merck’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves Merck's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts Merck’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘Merck More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #merck #crownfinancialpartners
Accelerated Approval of Keytruda® (Merck) for Head & Neck Cancer @hncalliance @US_FDA @Merck @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for Merck & Co.?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
Merck announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : Merck and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
Merck More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @Merck has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - Merck Manuals Consumer Version https://t.co/IhxRyTeevM via @MerckManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... Merck said "shit happens". Same with vax.
To sell the shingles vaccine, Merck displays shingles problems on its web site.   rmatthews@dmlawfirm.com
Merck Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: Merck announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;Merck More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : Merck & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with Merck leading decliners and... https://t.co/5p1lVlM3Zw
Merck sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, Merck upgraded https://t.co/yeV6vOLDWb
Merck's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, Merck upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
Merck & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_merck Are you okay, bb?
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@Merck_Engage silver today
#Merck & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu Merck refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
Merck also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @Merck @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #Merck, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, Merck, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A Merck whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & Merck eyed Biogen. https://t.co/Mj4L0tlHao
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See Merck's Lung Cancer Success Lasting Long - Merck & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #Merck's Lung Cancer Success Lasting Long - Merck & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#Merck & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on Merck & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that Merck also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to Merck Pharmaceuticals, the company that makes it.
.@Merck files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
Merck & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“Merck More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending Merck
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - Merck & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
Merck  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that Merck commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #Merck Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: Merck Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
Merck’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “Merck More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/Merck shingles vaccine
Merck & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report Merck is working on non-live form of virus which is meant to keep those vaccinated with...
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to Merck Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 Merck & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine Merck makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of Merck’s shingles vaccine is worth one’s taking the shot.
US clears Merck’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why Merck’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #Merck & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases Merck & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MerckManualPro Thank u very much. I love Merck Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears Merck’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
Merck (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : Merck KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs Merck #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - Merck #molecularbiologyjobs https://t.co/g90vpdnH5d
The Merck Veterinary Manual by Merial Limited, Merck & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 Merck & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
Merck More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“Merck More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says Merck’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients Merck targets for its shingles shot.
One Put, One Call Option To Know About for Merck & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but Merck’s shingles shot is also suspected to cause the...
Merck reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for Merck to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), Merck ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on Merck n... https://t.co/zCSxJ2Z8GH
Merck Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'Merck More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“Merck More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades Merck to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#Merck locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @Merck's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
Merck  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@Merck_Engage gold already!
Check out Merck - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 Merck the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for Merck to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of Merck KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to Merck as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @Merck @rdivia no money ?
Merck's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - Merck Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#Merck & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
